15 May 2024 11:51 am Views - 3089
Addressing the media, Dr. Ananda Wijewickrama, Chairman of the National Medicinal Drugs Regulatory Authority, referenced a case in which the manufacturer of AstraZeneca acknowledged that complications from the vaccine are exceedingly rare, a fact they had previously admitted.
He underscored that these rare complications are not indicative of future adverse effects, providing reassurance on the overall safety profile of the vaccine.